🇺🇸 FDA
Patent

US 12195540

Antibodies that bind integrin αvβ8 and uses thereof

granted A61KA61K2039/505A61P

Quick answer

US patent 12195540 (Antibodies that bind integrin αvβ8 and uses thereof) held by The Regents of the University of California expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/505, A61P, A61P35/00